Faron Pharmaceuticals Oy Financial Overview
Faron Pharmaceuticals Oy's market cap is currently £195.43M. The company's EPS TTM is p-0.13246776136; its P/E ratio is -6.93; Faron Pharmaceuticals Oy is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is p-0.10. See an overview of income statement, balance sheet, and cash flow financials.
